The biobank legislation of 2018, which is one of the most stringent biobanking-related legislations worldwide, imposed some major challenges for research groups with large patient and sample collections. I provide support and consulting to researchers for biobanking and use of their sample collections in research within the framework of evolving legislation.
Our biobank collections serve as the foundation for innovative research projects, with a focus on Alzheimer's disease, frontotemporal dementia and other neurodegenerative diseases (NDDs), aimed at advancing translational research and ultimately improving patient care.